ZILXI is a Topical Aerosol, Foam in the Human Prescription Drug category. It is labeled and distributed by Foamix Pharmaceuticals Inc.. The primary component is Minocycline Hydrochloride.
| Product ID | 72356-103_116f9ade-1bdc-4162-98d8-d3a0c592f419 |
| NDC | 72356-103 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ZILXI |
| Generic Name | Minocycline |
| Dosage Form | Aerosol, Foam |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2020-10-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA213690 |
| Labeler Name | Foamix Pharmaceuticals Inc. |
| Substance Name | MINOCYCLINE HYDROCHLORIDE |
| Active Ingredient Strength | 15 mg/g |
| Pharm Classes | Tetracycline-class Drug [EPC],Tetracyclines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-10-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 69489-212 | ZILXI | Minocycline |
| 72356-103 | ZILXI | Minocycline |
| 69489-201 | AMZEEQ | Minocycline |
| 72356-101 | AMZEEQ | Minocycline |
| 42291-589 | Minocycline | Minocycline |
| 42291-591 | Minocycline | Minocycline |
| 49884-511 | Minocycline | Minocycline |
| 49884-512 | Minocycline | Minocycline |
| 49884-513 | Minocycline | Minocycline |
| 63629-2228 | Minocycline | Minocycline |
| 63629-2229 | Minocycline | Minocycline |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZILXI 88758482 not registered Live/Pending |
Foamix Pharmaceuticals Ltd 2020-01-14 |